Michael Cilento

Michael Cilento

Adelaide Medical School

Faculty of Health and Medical Sciences

Dr Michael Cilento MBBS FRACP is a medical oncologist and PhD candidate in the Prostate Cancer Research Group at the South Australian Health and Medical Research Institute (SAHMRI) led by Professor Lisa Butler. Dr Cilento received his medical degree from the University of Adelaide and did his residency at the Royal Adelaide Hospital. He completed his oncology training in South Australia, which was followed by a fellowship in early drug development and phase 1 clinical trials at the Peter MacCallum Cancer Centre Melbourne. Dr Cilento joined the Flinders Centre for Innovation in Cancer as a consultant medical oncologist in 2024. His PhD research is utilising spatial profiling methods to identify novel metabolic drivers of lethal prostate cancer.

  • Journals
    Year Citation
    2024 Cilento, M. A., Sweeney, C. J., & Butler, L. M. (2024). Spatial transcriptomics in cancer research and potential clinical impact: a narrative review. Journal of Cancer Research and Clinical Oncology, 150(6), 296-1-296-16.
    DOI Scopus5 Europe PMC4
    2022 Cilento, M. A., Klein, O., Egan, E., & Roberts-Thomson, R. (2022). Talimogene laherparepvec resulting in near-complete response in a patient with treatment-refractory Merkel cell carcinoma. Australasian Journal of Dermatology, 63(3), e222-e225.
    DOI Scopus7 WoS3 Europe PMC6
    2022 Cilento, M. A., Kim, C., Chang, S., Farshid, G., & Brown, M. P. (2022). Three cases of BRAF-mutant melanoma with divergent differentiation masquerading as sarcoma. Pathologica, 114(3), 217-220.
    DOI Scopus6 WoS2 Europe PMC4
    2021 Cilento, M. A., & Hocking, C. M. (2021). Cystic and cavitating lung lesions as a presenting finding of metastatic prostate cancer. Medical Journal of Australia, 214(10), 459-459.e1.
    DOI Scopus2 Europe PMC1
    2021 Cilento, M. A., Poplawski, N. K., Paramasivam, S., Thomas, D. M., & Kichenadasse, G. (2021). Germline PALB2 variants and PARP inhibitors in endometrial cancer. JNCCN Journal of the National Comprehensive Cancer Network, 19(11), 1212-1217.
    DOI Scopus5 WoS2 Europe PMC5

  • Conference Items
    Year Citation
    2023 Cilento, M. A., Mah, C. Y., Martelotto, L., Sweeney, C. J., & Butler, L. M. (2023). Multiomic analysis workflow for biomarker discovery in human prostate cancer. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY.
    2022 Cilento, M. A., Chalwin, R., Hocking, C., Chan, L., Smithers, L., & Joshi, R. (2022). MORBIDITY AND MORTALITY OF ONCOLOGY PATIENTS ADMITTED TO AN INTENSIVE CARE UNIT. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
    2021 Cilento, M., & Roberts-Thomson, R. (2021). Weight changes during adjuvant nivolumab for resected melanoma. Poster session presented at the meeting of Poster Abstracts. Asia-Pacific Journal of Clinical Oncology, 17: 110-208.. Virtual.
    DOI
Connect With Me
External Profiles